Completed PHASE4 INTERVENTIONAL 2-arm NCT00000378

Antidepressant Treatment of Melancholia in Late Life

Antidepressant Treatment of Melancholia in Late :Ife

Sponsor: National Institute of Mental Health (NIMH)

Updated 5 times since 2017 Last updated: Oct 6, 2015 Started: Jul 31, 1997 Primary completion: Jun 30, 2002 Completion: Jun 30, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Depression and Melancholia and is currently completed. National Institute of Mental Health (NIMH) leads this study, which shows 5 recorded versions since 1997 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)
New York State Psychiatric Institute

Data source: New York State Psychiatric Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States